Submitted:
15 September 2023
Posted:
19 September 2023
Read the latest preprint version here
Abstract
Keywords:
1. Introduction
2. Genes and Proteins
2.1. KIF11
2.2. ZNF408
2.3. CTNNB1
2.4. NDP
2.5. FZD4
2.6. LRP5
2.7. TSPAN-12
3. Conclusions
- As we survey the protein domain maps that we have presented of currently known pathogenic and likely-pathogenic variants; we can conclude that almost any functional subdomain of these proteins can be involved. This is not surprising as studies of these proteins have established important protein-interaction functions or structural functions that are essential for their normal biological activity. Generally, there are little if any non-essential regions in the seven proteins reviewed.
- FEVR can involve the disruption of any one of several different functions in endothelial cells, not just those related directly to the Norrin Wnt-signaling pathway. This is established by disease-causing variants in ZNF408 and KIF11. However, what all these genes and their protein products have in common is that they are particularly important for critical retinal endothelial cell activity. These include growth, proliferation, and migration of endothelial cells during formation of the retinal vasculature and maturation of a high-barrier endothelium. It is possible, and expected, that we may continue to discover novel FEVR-linked genes and good candidates would be any gene that is particularly enriched in retinal endothelial cells versus other endothelial cells, and genes with the potential to impact EC proliferation or the maturation of their high-barrier character.
- The multiple allele knockout studies by Junge et al., (2009) in mice suggested the possibility that more severe FEVR-like phenotypes could result from combinations of two or more different alleles that have a minimal impact alone [56]. Our group recently surveyed a cohort of FEVR patients and immediate relatives to confirm that the incidence of protein-altering variants in two or three different FEVR-linked genes was substantially greater than in the general population [12]. Thus, it is possible that combined mild-alleles might result in more severe phenotypes, but we have not yet described clear examples of this in FEVR. To explore such possibilities for this relatively rare condition it will be helpful to apply genetic testing methods that survey as many genes as possible and to form global research collaborations to investigate genotypes and phenotypes from varied populations.
Author Contributions
Funding
Institutional Review Board Statement
Conflicts of Interest
References
- Fruttiger, M. Development of the mouse retinal vasculature: angiogenesis versus vasculogenesis. Invest Ophthalmol Vis. Sci. 2002, 43. [Google Scholar]
- Zuercher, J.; Fritzsche, M.; Feil, S.; Mohn, L.; Berger, W. Norrin stimulates cell proliferation in the superficial retinal vascular plexus and is pivotal for the recruitment of mural cells. Hum. Mol. Genet. 2012, 21, 2619–2630. [Google Scholar] [CrossRef]
- Selvam, S.; Kumar, T.; Fruttiger, M. Retinal vasculature development in health and disease. Prog. Retin. Eye Res. 2018, 63, 1–19. [Google Scholar] [CrossRef] [PubMed]
- Tokunaga, C.C.; Mitton, K.P.; Dailey, W.; Massoll, C.; Roumayah, K.; Guzman, E.; Tarabishy, N.; Cheng, M.; Drenser, K.A. Effects of Anti-VEGF Treatment on the Recovery of the Developing Retina Following Oxygen-Induced Retinopathy. Investig. Opthalmology Vis. Sci. 2014, 55, 1884–1892. [Google Scholar] [CrossRef] [PubMed]
- Dailey, W.A.; Drenser, K.A.; Wong, S.C.; Cheng, M.; Vercellone, J.; Roumayah, K.K.; Feeney, E.V.; Deshpande, M.; Guzman, A.E.; Trese, M.; et al. Ocular coherence tomography image data of the retinal laminar structure in a mouse model of oxygen-induced retinopathy. Data Brief 2017, 15, 491–495. [Google Scholar] [CrossRef] [PubMed]
- Dailey, W.A.; Drenser, K.A.; Wong, S.C.; Cheng, M.; Vercellone, J.; Roumayah, K.K.; Feeney, E.V.; Deshpande, M.; Guzman, A.E.; Trese, M.; et al. Norrin treatment improves ganglion cell survival in an oxygen-induced retinopathy model of retinal ischemia. Exp. Eye Res. 2017, 164, 129–138. [Google Scholar] [CrossRef]
- Fresta, C.G.; Fidilio, A.; Caruso, G.; Caraci, F.; Giblin, F.J.; Leggio, G.M.; Salomone, S.; Drago, F.; Bucolo, C. A New Human Blood–Retinal Barrier Model Based on Endothelial Cells, Pericytes, and Astrocytes. Int. J. Mol. Sci. 2020, 21, 1636. [Google Scholar] [CrossRef]
- Glenney, J.R.; Soppet, D. Sequence and expression of caveolin, a protein component of caveolae plasma membrane domains phosphorylated on tyrosine in Rous sarcoma virus-transformed fibroblasts. . 1992, 89, 10517–10521. [Google Scholar] [CrossRef]
- Gardner, T.W.; Antonetti, D.A.; Barber, A.J.; Lanoue, K.F.; Levison, S.W.; Penn, T.; Retina, S.; Group, R. Diabetic Retinopathy: More Than Meets the Eye; 2002; Vol. 47.
- Feng, Y.; Venema, V.J.; Venema, R.C.; Tsai, N.; Caldwell, R.B. VEGF Induces Nuclear Translocation of Flk-1/KDR, Endothelial Nitric Oxide Synthase, and Caveolin-1 in Vascular Endothelial Cells. Biochem. Biophys. Res. Commun. 1999, 256, 192–197. [Google Scholar] [CrossRef]
- Scruggs, B.A.; Reding, M.Q.; Schimmenti, L.A. NDP-Related Retinopathies. GeneReviews® 2022.
- Cicerone, A.P.; Dailey, W.; Sun, M.; Santos, A.; Jeong, D.; Jones, L.; Koustas, K.; Drekh, M.; Schmitz, K.; Haque, N.; et al. A Survey of Multigenic Protein-Altering Variant Frequency in Familial Exudative Vitreo-Retinopathy (FEVR) Patients by Targeted Sequencing of Seven FEVR-Linked Genes. Genes 2022, 13, 495. [Google Scholar] [CrossRef]
- Dixon, M.W.; Stem, M.S.; Schuette, J.L.; Keegan, C.E.; Besirli, C.G. CTNNB1 mutation associated with familial exudative vitreoretinopathy (FEVR) phenotype. Ophthalmic Genet. 2016, 37, 468–470. [Google Scholar] [CrossRef]
- Li, J.-K.; Fei, P.; Li, Y.; Huang, Q.-J.; Zhang, Q.; Zhang, X.; Rao, Y.-Q.; Li, J.; Zhao, P. Identification of novel KIF11 mutations in patients with familial exudative vitreoretinopathy and a phenotypic analysis. Sci. Rep. 2016, 6, 26564. [Google Scholar] [CrossRef]
- Collin, R.W.J.; Nikopoulos, K.; Dona, M.; Gilissen, C.; Hoischen, A.; Boonstra, F.N.; Poulter, J.A.; Kondo, H.; Berger, W.; Toomes, C.; et al. ZNF408 is mutated in familial exudative vitreoretinopathy and is crucial for the development of zebrafish retinal vasculature. 2013, 110, 9856–9861. [CrossRef]
- Kashlna, A.S.; Baskin, R.J.; Cole, D.G.; Wedaman, K.P.; Saxton, W.M.; Scholey, J.M. A bipolar kinesin. Nature 1996, 379, 270–272. [Google Scholar] [CrossRef]
- E Jones, G.; Ostergaard, P.; Moore, A.T.; Connell, F.C.; Williams, D.; Quarrell, O.; Brady, A.F.; Spier, I.; Hazan, F.; Moldovan, O.; et al. Microcephaly with or without chorioretinopathy, lymphoedema, or mental retardation (MCLMR): review of phenotype associated with KIF11 mutations. Eur. J. Hum. Genet. 2013, 22, 881–887. [Google Scholar] [CrossRef] [PubMed]
- Mirzaa, G.M.; Enyedi, L.; Parsons, G.; Collins, S.; Medne, L.; Adams, C.; Ward, T.; Davitt, B.; Bicknese, A.; Zackai, E.; et al. Congenital microcephaly and chorioretinopathy due to de novo heterozygousKIF11mutations: Five novel mutations and review of the literature. Am. J. Med Genet. Part A 2014, 164, 2879–2886. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Smallwood, P.M.; Williams, J.; Nathans, J. A mouse model for kinesin family member 11 (Kif11)-associated familial exudative vitreoretinopathy. Hum. Mol. Genet. 2020, 29, 1121–1131. [Google Scholar] [CrossRef]
- Di Zazzo, E.; De Rosa, C.; Abbondanza, C.; Moncharmont, B. PRDM Proteins: Molecular Mechanisms in Signal Transduction and Transcriptional Regulation. Biology 2013, 2, 107–141. [Google Scholar] [CrossRef]
- Cassandri, M.; Smirnov, A.; Novelli, F.; Pitolli, C.; Agostini, M.; Malewicz, M.; Melino, G.; Raschellà, G. Zinc-finger proteins in health and disease. Cell Death Discov. 2017, 3, 17071–17071. [Google Scholar] [CrossRef]
- Avila-Fernandez, A.; Perez-Carro, R.; Corton, M.; Lopez-Molina, M.I.; Campello, L.; Garanto, A.; Fernandez-Sanchez, L.; Duijkers, L.; Lopez-Martinez, M.A.; Riveiro-Alvarez, R.; et al. Whole-exome sequencing reveals ZNF408 as a new gene associated with autosomal recessive retinitis pigmentosa with vitreal alterations. Hum. Mol. Genet. 2015, 24, 4037–4048. [Google Scholar] [CrossRef]
- Karjosukarso, D.W.; van Gestel, S.H.C.; Qu, J.; Kouwenhoven, E.N.; Duijkers, L.; Garanto, A.; Zhou, H.; Collin, R.W.J. An FEVR-associated mutation in ZNF408 alters the expression of genes involved in the development of vasculature. Hum. Mol. Genet. 2018, 27, 3519–3527. [Google Scholar] [CrossRef] [PubMed]
- Xu, W.; Kimelman, D. Mechanistic insights from structural studies of β-catenin and its binding partners. J. Cell Sci. 2007, 120, 3337–3344. [Google Scholar] [CrossRef]
- Huber, A.H.; Weis, W.I. The Structure of the β-Catenin/E-Cadherin Complex and the Molecular Basis of Diverse Ligand Recognition by β-Catenin. Cell 2001, 105, 391–402. [Google Scholar] [CrossRef]
- Xu, W.; Kimelman, D. Mechanistic insights from structural studies of β-catenin and its binding partners. J. Cell Sci. 2007, 120, 3337–3344. [Google Scholar] [CrossRef]
- Taylor, R.L.; Soriano, C.S.; Williams, S.; Dzulova, D.; Ashworth, J.; Hall, G.; Gale, T.; Lloyd, I.C.; Inglehearn, C.F.; Toomes, C.; et al. Bi-allelic mutation of CTNNB1 causes a severe form of syndromic microphthalmia, persistent foetal vasculature and vitreoretinal dysplasia. Orphanet J. Rare Dis. 2022, 17, 1–8. [Google Scholar] [CrossRef]
- Ohlmann, A.; Tamm, E.R. Norrin: Molecular and functional properties of an angiogenic and neuroprotective growth factor. Prog. Retin. Eye Res. 2012, 31, 243–257. [Google Scholar] [CrossRef] [PubMed]
- Zeilbeck, L.F.; Müller, B.B.; Leopold, S.A.; Senturk, B.; Langmann, T.; Tamm, E.R.; Ohlmann, A. Norrin mediates angiogenic properties via the induction of insulin-like growth factor-1. Exp. Eye Res. 2016, 145, 317–326. [Google Scholar] [CrossRef]
- Shastry, B.S.; Hejtmancik, J.F.; Trese, M.T. Identification of Novel Missense Mutations in the Norrie Disease Gene Associated with One X-Linked and Four Sporadic Cases of Familial Exudative Vitreoretinopathy. Hum Mutat 1997, 9, 396–401. [Google Scholar] [CrossRef]
- Ke, J.; Harikumar, K.G.; Erice, C.; Chen, C.; Gu, X.; Wang, L.; Parker, N.; Cheng, Z.; Xu, W.; Williams, B.O.; et al. Structure and function of Norrin in assembly and activation of a Frizzled 4–Lrp5/6 complex. Genes Dev. 2013, 27, 2305–2319. [Google Scholar] [CrossRef] [PubMed]
- Xu, Q.; Wang, Y.; Dabdoub, A.; Smallwood, P.M.; Williams, J.; Woods, C.; Kelley, M.W.; Jiang, L.; Tasman, W.; Zhang, K.; et al. Vascular Development in the Retina and Inner Ear: Control by Norrin and Frizzled-4, a High-Affinity Ligand-Receptor Pair. Cell 2004, 116, 883–895. [Google Scholar] [CrossRef]
- Wu, W.-C.; Drenser, K.; Trese, M.; Capone, A.; Dailey, W. Retinal Phenotype–Genotype Correlation of Pediatric Patients Expressing Mutations in the Norrie Disease Gene. Arch. Ophthalmol. 2007, 125, 225–230. [Google Scholar] [CrossRef] [PubMed]
- Xiao, H.; Tong, Y.; Zhu, Y.; Peng, M. Familial Exudative Vitreoretinopathy-Related Disease-Causing Genes and Norrin/β-Catenin Signal Pathway: Structure, Function, and Mutation Spectrums. J. Ophthalmol. 2019, 2019, 1–24. [Google Scholar] [CrossRef] [PubMed]
- Wang, Y.; Cho, C.; Williams, J.; Smallwood, P.M.; Zhang, C.; Junge, H.J.; Nathans, J. Interplay of the Norrin and Wnt7a/Wnt7b signaling systems in blood–brain barrier and blood–retina barrier development and maintenance. Proc. Natl. Acad. Sci. 2018, 115, E11827–E11836. [Google Scholar] [CrossRef]
- Ye, X.; Wang, Y.; Nathans, J. The Norrin/Frizzled4 signaling pathway in retinal vascular development and disease. Trends Mol. Med. 2010, 16, 417–425. [Google Scholar] [CrossRef] [PubMed]
- Ohlmann, A.; Scholz, M.; Goldwich, A.; Chauhan, B.K.; Hudl, K.; Ohlmann, A.V.; Zrenner, E.; Berger, W.; Cvekl, A.; Seeliger, M.W.; et al. Ectopic Norrin Induces Growth of Ocular Capillaries and Restores Normal Retinal Angiogenesis in Norrie Disease Mutant Mice. J. Neurosci. 2005, 25, 1701–1710. [Google Scholar] [CrossRef] [PubMed]
- Díaz-Coránguez, M.; Lin, C.-M.; Liebner, S.; Antonetti, D.A. Norrin restores blood-retinal barrier properties after vascular endothelial growth factor–induced permeability. J. Biol. Chem. 2020, 295, 4647–4660. [Google Scholar] [CrossRef]
- Tokunaga, C.C.; Chen, Y.-H.; Dailey, W.; Cheng, M.; Drenser, K.A. Retinal Vascular Rescue of Oxygen-Induced Retinopathy in Mice by Norrin. Investig. Opthalmology Vis. Sci. 2013, 54, 222–229. [Google Scholar] [CrossRef]
- Bang, I.; Kim, H.R.; Beaven, A.H.; Kim, J.; Ko, S.-B.; Lee, G.R.; Kan, W.; Lee, H.; Im, W.; Seok, C.; et al. Biophysical and functional characterization of Norrin signaling through Frizzled4. Proc. Natl. Acad. Sci. 2018, 115, 8787–8792. [Google Scholar] [CrossRef]
- Paes, K.T.; Wang, E.; Henze, K.; Vogel, P.; Read, R.; Suwanichkul, A.; Kirkpatrick, L.L.; Potter, D.; Newhouse, M.M.; Rice, D.S. Frizzled 4 Is Required for Retinal Angiogenesis and Maintenance of the Blood-Retina Barrier. Investig. Opthalmology Vis. Sci. 2011, 52, 6452–6461. [Google Scholar] [CrossRef] [PubMed]
- Kondo, H.; Hayashi, H.; Oshima, K.; Tahira, T.; Hayashi, K. Frizzled 4 gene (FZD4) mutations in patients with familial exudative vitreoretinopathy with variable expressivity. Br. J. Ophthalmol. 2003, 87, 1291–1295. [Google Scholar] [CrossRef]
- Dailey, W.A.; Gryc, W.; Garg, P.G.; Drenser, K.A. Frizzled-4 Variations Associated with Retinopathy and Intrauterine Growth Retardation. Ophthalmology 2015, 122, 1917–1923. [Google Scholar] [CrossRef]
- Cicerone, A.P.; Dailey, W.; Sun, M.; Santos, A.; Jeong, D.; Jones, L.; Koustas, K.; Drekh, M.; Schmitz, K.; Haque, N.; et al. A Survey of Multigenic Protein-Altering Variant Frequency in Familial Exudative Vitreo-Retinopathy (FEVR) Patients by Targeted Sequencing of Seven FEVR-Linked Genes. Genes 2022, 13, 495. [Google Scholar] [CrossRef] [PubMed]
- He, X.; Semenov, M.; Tamai, K.; Zeng, X. , LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 2004, 131, 1663–1677. [Google Scholar] [CrossRef] [PubMed]
- Xia, C.-H.; Yablonka-Reuveni, Z.; Gong, X. LRP5 Is Required for Vascular Development in Deeper Layers of the Retina. PLOS ONE 2010, 5, e11676. [Google Scholar] [CrossRef] [PubMed]
- Huang, W.; Li, Q.; Amiry-Moghaddam, M.; Hokama, M.; Sardi, S.H.; Nagao, M.; Warman, M.L.; Olsen, B.R. Critical Endothelial Regulation by LRP5 during Retinal Vascular Development. PLOS ONE 2016, 11, e0152833. [Google Scholar] [CrossRef]
- He, X.; Semenov, M.; Tamai, K.; Zeng, X. , LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development 2004, 131, 1663–1677. [Google Scholar] [CrossRef]
- Qin, M.; Hayashi, H.; Oshima, K.; Tahira, T.; Hayashi, K.; Kondo, H. Complexity of the genotype-phenotype correlation in familial exudative vitreoretinopathy with mutations in theLRP5and/orFZD4genes. Hum. Mutat. 2005, 26, 104–112. [Google Scholar] [CrossRef] [PubMed]
- Seigneuret, M.; Delaguillaumie, A.; Lagaudrière-Gesbert, C.; Conjeaud, H. Structure of the Tetraspanin Main Extracellular Domain. J. Biol. Chem. 2001, 276, 40055–40064. [Google Scholar] [CrossRef]
- Poulter, J.A.; Ali, M.; Gilmour, D.F.; Rice, A.; Kondo, H.; Hayashi, K.; Mackey, D.A.; Kearns, L.S.; Ruddle, J.B.; Craig, J.E.; et al. Mutations in TSPAN12 Cause Autosomal-Dominant Familial Exudative Vitreoretinopathy. Am. J. Hum. Genet. 2010, 86, 248–253. [Google Scholar] [CrossRef]
- Zhang, C.; Lai, M.B.; Pedler, M.G.; Johnson, V.; Adams, R.H.; Petrash, J.M.; Chen, Z.; Junge, H.J. Endothelial Cell–Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature. Arter. Thromb. Vasc. Biol. 2018, 38, 2691–2705. [Google Scholar] [CrossRef] [PubMed]
- Charrin, S.; Jouannet, S.; Boucheix, C.; Rubinstein, E. Tetraspanins at a glance. J. Cell Sci. 2014, 127, 3641–3648. [Google Scholar] [CrossRef] [PubMed]
- Yusoff, A.A.M.; Khair, S.Z.N.M.; Ismail, A.S.; Embong, Z. Detection of FZD4, LRP5 and TSPAN12 genes variants in Malay premature babies with retinopathy of prematurity. J. Ophthalmic Vis. Res. 2019, 14, 171–178. [Google Scholar] [CrossRef] [PubMed]
- Nikopoulos, K.; Gilissen, C.; Hoischen, A.; van Nouhuys, C.E.; Boonstra, F.N.; Blokland, E.A.; Arts, P.; Wieskamp, N.; Strom, T.M.; Ayuso, C.; et al. Next-Generation Sequencing of a 40 Mb Linkage Interval Reveals TSPAN12 Mutations in Patients with Familial Exudative Vitreoretinopathy. Am. J. Hum. Genet. 2010, 86, 240–247. [Google Scholar] [CrossRef] [PubMed]
- Junge, H.J.; Yang, S.; Burton, J.B.; Paes, K.; Shu, X.; French, D.M.; Costa, M.; Rice, D.S.; Ye, W. TSPAN12 Regulates Retinal Vascular Development by Promoting Norrin- but Not Wnt-Induced FZD4/β-Catenin Signaling. Cell 2009, 139, 299–311. [Google Scholar] [CrossRef] [PubMed]
- Zhang, C.; Lai, M.B.; Pedler, M.G.; Johnson, V.; Adams, R.H.; Petrash, J.M.; Chen, Z.; Junge, H.J. Endothelial Cell–Specific Inactivation of TSPAN12 (Tetraspanin 12) Reveals Pathological Consequences of Barrier Defects in an Otherwise Intact Vasculature. Arter. Thromb. Vasc. Biol. 2018, 38, 2691–2705. [Google Scholar] [CrossRef] [PubMed]









Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions, or products referred to in the content. |
© 2023 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).